Adenine base editing is used in vivo to correct a common mutation that causes hypertrophic cardiomyopathy (HCM),...
Adenine base editing is used in vivo to correct a common mutation that causes hypertrophic cardiomyopathy (HCM), a disease that occurs in ~1 in 500 people.
Adenine base editing is used in vivo to correct a common mutation that causes hypertrophic cardiomyopathy (HCM), a disease that occurs in ~1 in 500 people.
Adenine base editing is used in vivo to correct a common mutation that causes hypertrophic cardiomyopathy (HCM), a disease that occurs in ~1 in 500 people.
